Literature DB >> 25421208

Methionine Exposure Alters Glutamate Uptake and Adenine Nucleotide Hydrolysis in the Zebrafish Brain.

Fernanda Cenci Vuaden1, Luiz Eduardo Baggio Savio2, Eduardo Pacheco Rico2, Ben Hur Marins Mussulini2, Denis Broock Rosemberg3, Diogo Losch de Oliveira2, Maurício Reis Bogo4, Carla Denise Bonan4,5, Angela T S Wyse6.   

Abstract

Hypermethioninemic patients may exhibit different neurological dysfunctions, and the mechanisms underlying these pathologies remain obscure. Glutamate and ATP are important excitatory neurotransmitters co-released at synaptic clefts, and whose activities are intrinsically related. Adenosine-the final product of ATP breakdown-is also an important neuromodulator. Here, we investigated the effects of long-term (7-day) exposure to 1.5 or 3 mM methionine (Met) on glutamate uptake in brain tissues (telencephalon, optic tectum, and cerebellum) and on ATP, ADP, and AMP catabolism by ecto-nucleotidases found in brain membrane samples, using a zebrafish model. Also, we evaluated the expression of ecto-nucleotidase (ntdp1, ntdp2mg, ntdp2mq, ntdp2mv, ntdp3, and nt5e) and adenosine receptor (adora1, adora2aa, adora2ab, adora2b) genes in the brain of zebrafish exposed to Met. In animals exposed to 3.0 mM Met, glutamate uptake in the telencephalon decreased significantly. Also, ATP and ADP (but not AMP) catabolism decreased significantly at both Met concentrations tested. The messenger RNA (mRNA) levels of ntpd genes and of the adenosine receptors adora1 and adora2aa increased significantly after Met exposure. In contrast, adora2ab mRNA levels decreased after Met exposure. Our data suggest that glutamate and ATP accumulate at synaptic clefts after Met exposure, with potential detrimental effects to the nervous system. This phenomenon might explain, at least in part, the increased susceptibility of hypermethioninemic patients to neurological symptoms.

Entities:  

Keywords:  Glutamate uptake; Hypermethioninemia; Inherited diseases; Methionine; Nucleotide catabolism; Zebrafish

Mesh:

Substances:

Year:  2014        PMID: 25421208     DOI: 10.1007/s12035-014-8983-3

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  73 in total

Review 1.  Nucleotide signaling in nervous system development.

Authors:  Herbert Zimmermann
Journal:  Pflugers Arch       Date:  2006-04-25       Impact factor: 3.657

Review 2.  Glutamate transporters: diversity, function, and involvement in neurologic disease.

Authors:  Eduardo E Benarroch
Journal:  Neurology       Date:  2010-01-19       Impact factor: 9.910

Review 3.  Purinergic signalling: from normal behaviour to pathological brain function.

Authors:  Geoffrey Burnstock; Ute Krügel; Maria P Abbracchio; Peter Illes
Journal:  Prog Neurobiol       Date:  2011-09-01       Impact factor: 11.685

4.  Methionine Adenosyltransferase I/III Deficiency in Portugal: High Frequency of a Dominantly Inherited Form in a Small Area of Douro High Lands.

Authors:  E Martins; A Marcão; A Bandeira; H Fonseca; C Nogueira; L Vilarinho
Journal:  JIMD Rep       Date:  2012-02-01

5.  A direct colorimetric assay for Ca2+ -stimulated ATPase activity.

Authors:  K M Chan; D Delfert; K D Junger
Journal:  Anal Biochem       Date:  1986-09       Impact factor: 3.365

6.  Acute and chronic hypermethioninemia alter Na+ K+-ATPase activity in rat hippocampus: prevention by antioxidants.

Authors:  Francieli M Stefanello; Andréa G K Ferreira; Talita C B Pereira; Maira J da Cunha; Carla D Bonan; Maurício R Bogo; Angela T S Wyse
Journal:  Int J Dev Neurosci       Date:  2011-02-24       Impact factor: 2.457

7.  Unique functional properties of a sensory neuronal P2X ATP-gated channel from zebrafish.

Authors:  E Boué-Grabot; M A Akimenko; P Séguéla
Journal:  J Neurochem       Date:  2000-10       Impact factor: 5.372

Review 8.  Tryptophan, adenosine, neurodegeneration and neuroprotection.

Authors:  T W Stone; C M Forrest; G M Mackay; N Stoy; L G Darlington
Journal:  Metab Brain Dis       Date:  2007-12       Impact factor: 3.584

Review 9.  Nucleotide- and nucleoside-converting ectoenzymes: Important modulators of purinergic signalling cascade.

Authors:  Gennady G Yegutkin
Journal:  Biochim Biophys Acta       Date:  2008-02-12

Review 10.  Oxidative stress, glutamate, and neurodegenerative disorders.

Authors:  J T Coyle; P Puttfarcken
Journal:  Science       Date:  1993-10-29       Impact factor: 47.728

View more
  4 in total

1.  Cholinergic System and Oxidative Stress Changes in the Brain of a Zebrafish Model Chronically Exposed to Ethanol.

Authors:  Jotele Fontana Agostini; Helena Cristina Zuehl Dal Toé; Karine Medeiros Vieira; Samira Leila Baldin; Naithan Ludian Fernandes Costa; Carolina Uribe Cruz; Larisse Longo; Marcel Marcos Machado; Themis Reverbel da Silveira; Patrícia Fernanda Schuck; Eduardo Pacheco Rico
Journal:  Neurotox Res       Date:  2017-09-23       Impact factor: 3.911

2.  Methionine and methionine sulfoxide treatment induces M1/classical macrophage polarization and modulates oxidative stress and purinergic signaling parameters.

Authors:  Lien M Dos Santos; Tatiane M da Silva; Juliana H Azambuja; Priscila T Ramos; Pathise S Oliveira; Elita F da Silveira; Nathalia S Pedra; Kennia Galdino; Carlus A T do Couto; Mayara S P Soares; Rejane G Tavares; Roselia M Spanevello; Francieli M Stefanello; Elizandra Braganhol
Journal:  Mol Cell Biochem       Date:  2016-10-17       Impact factor: 3.396

3.  Paternal exposure to excessive methionine altered behavior and neurochemical activities in zebrafish offspring.

Authors:  Rodrigo Zanandrea; Melissa Talita Wiprich; Stefani Altenhofen; Gabriel Rubensam; Tiago Marcon Dos Santos; Angela T S Wyse; Carla Denise Bonan
Journal:  Amino Acids       Date:  2021-06-22       Impact factor: 3.520

4.  Withdrawal Effects Following Methionine Exposure in Adult Zebrafish.

Authors:  Rodrigo Zanandrea; Melissa Talita Wiprich; Stefani Altenhofen; Gabriel Rubensam; Tiago Marcon Dos Santos; Angela T S Wyse; Carla Denise Bonan
Journal:  Mol Neurobiol       Date:  2020-06-12       Impact factor: 5.682

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.